{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:13:03Z","timestamp":1793502783508,"version":"4.5.0"},"reference-count":180,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007195","name":"Universit\u00e0 degli Studi di Napoli Federico II","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015410","name":"Societ\u00e0 Italiana di Medicina Interna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jaci.2025.02.018","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T11:50:23Z","timestamp":1740397823000},"page":"1420-1434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["TL1A, a novel alarmin in airway, intestinal, and autoimmune disorders"],"prefix":"10.1016","volume":"155","author":[{"given":"Gilda","family":"Varricchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Poto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gjada","family":"Criscuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Strisciuglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswaran","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Marone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.02.018_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.coi.2005.06.002","article-title":"Alarmins: chemotactic activators of immune responses","volume":"17","author":"Oppenheim","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41577-022-00735-y","article-title":"Role of thymic stromal lymphopoietin in allergy and beyond","volume":"23","author":"Ebina-Shibuya","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib3","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3389\/fimmu.2018.01595","article-title":"Thymic stromal lymphopoietin isoforms, inflammatory disorders, and cancer","volume":"9","author":"Varricchi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib4","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/s41590-019-0524-9","article-title":"TSLP: from allergy to cancer","volume":"20","author":"Corren","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155891","article-title":"Interleukin-33 (IL-33): a critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine","volume":"156","author":"Cayrol","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2025.02.018_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imr.12552","article-title":"IL-33: biological properties, functions, and roles in airway disease","volume":"278","author":"Drake","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2025.02.018_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.894163","article-title":"Differential effects of alarmins on human and mouse basophils","volume":"13","author":"Gambardella","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082012","article-title":"Human lung-resident macrophages express and are targets of thymic stromal lymphopoietin in the tumor microenvironment","volume":"10","author":"Braile","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2025.02.018_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14728222.2020.1783242","article-title":"Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma","volume":"24","author":"Gauvreau","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jaci.2025.02.018_bib10","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.3390\/ijms25074049","article-title":"Thymic stromal lymphopoietin (TSLP) is cleaved by human mast cell tryptase and chymase","volume":"25","author":"Cane","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2025.02.018_bib11","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.4049\/jimmunol.179.2.1080","article-title":"TLR3- and Th2 cytokine\u2013dependent production of thymic stromal lymphopoietin in human airway epithelial cells","volume":"179","author":"Kato","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jaci.2012.07.031","article-title":"Thymic stromal lymphopoietin is induced by respiratory syncytial virus\u2013infected airway epithelial cells and promotes a type 2 response to infection","volume":"130","author":"Lee","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib13","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1073\/pnas.0607305104","article-title":"Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB","volume":"104","author":"Lee","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.02.018_bib14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jaci.2010.09.002","article-title":"Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2\u2013Toll-like receptor 6 pathway","volume":"126","author":"Vu","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejim.2024.02.020","article-title":"TSLP is localized in and released from human lung macrophages activated by T2-high and T2-low stimuli: relevance in asthma and COPD","volume":"124","author":"Cane","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib16","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2353\/ajpath.2008.080014","article-title":"Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation","volume":"173","author":"Kuchler","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2025.02.018_bib17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1\u2013like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in\u00a0vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.02.018_bib18","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1038\/s41467-018-05485-x","article-title":"Chromatin regulates IL-33 release and extracellular cytokine activity","volume":"9","author":"Travers","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.02.018_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1\u2013like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in\u00a0vivo: a novel \u201calarmin\u201d?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2025.02.018_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jid.2021.05.033","article-title":"Nuclear IL-33 plays an important role in IL-31\u2013mediated downregulation of FLG, keratin 1, and keratin 10 by regulating signal transducer and activator of transcription 3 activation in human keratinocytes","volume":"142","author":"Dai","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.02.018_bib21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.02.018_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1\u2013like cytokine that signals via the IL-1 receptor\u2013related protein ST2 and induces T helper type 2\u2013associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.02.018_bib23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02210-2022","article-title":"Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE\/EGFR signalling complex","volume":"62","author":"Strickson","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.02.018_bib24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41590-022-01255-6","article-title":"Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion","volume":"23","author":"Chen","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib25","article-title":"Epithelial IL-33 appropriates exosome trafficking for secretion in chronic airway disease","volume":"6","author":"Katz-Kiriakos","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2025.02.018_bib26","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.02.018_bib27","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaci.2022.07.003","article-title":"TSLP, IL-33, and IL-25: not just for allergy and helminth infection","volume":"150","author":"Stanbery","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.166136","article-title":"Tuft cells are required for a rhinovirus-induced asthma phenotype in immature mice","volume":"9","author":"Li","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2025.02.018_bib29","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231236","article-title":"TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation","volume":"221","author":"Schmitt","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fimmu.2019.00583","article-title":"TL1A (TNFSF15) and DR3 (TNFRSF25): a co-stimulatory system of cytokines with diverse functions in gut mucosal immunity","volume":"10","author":"Valatas","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jaci.2015.04.011","article-title":"Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin","volume":"136","author":"Fornasa","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1165\/rcmb.2009-0418OC","article-title":"Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma","volume":"44","author":"Harada","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2025.02.018_bib33","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/cea.14562","article-title":"Epithelial interleukin-1 receptor\u2013like-1 activation is contingent on interleukin-33 isoforms and asthma-related receptor variation","volume":"54","author":"Portelli","year":"2024","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2025.02.018_bib34","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1002\/cam4.4060","article-title":"Interleukin-25: new perspective and state-of-the-art in cancer prognosis and treatment approaches","volume":"10","author":"Gowhari Shabgah","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib35","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/gerona\/glq129","article-title":"Two functionally distinct isoforms of TL1A (TNFSF15) generated by differential ectodomain shedding","volume":"65","author":"Muck","year":"2010","journal-title":"J Gerontol A\u00a0Biol Sci Med Sci"},{"key":"10.1016\/j.jaci.2025.02.018_bib36","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jaci.2016.08.040","article-title":"Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in humans","volume":"139","author":"Poposki","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155961","article-title":"IL-33 biology in cancer: an update and future perspectives","volume":"157","author":"Yeoh","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2025.02.018_bib38","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/s41590-021-01011-2","article-title":"Environmental allergens trigger type 2 inflammation through ripoptosome activation","volume":"22","author":"Brusilovsky","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41590-018-0067-5","article-title":"Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33","volume":"19","author":"Cayrol","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib40","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1410700111","article-title":"Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells","volume":"111","author":"Lefrancais","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.02.018_bib41","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/s41598-018-21589-2","article-title":"Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage","volume":"8","author":"Scott","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2025.02.018_bib42","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1096\/fj.11-200618","article-title":"The death receptor 3\/TL1A pathway is essential for efficient development of antiviral CD4+ and CD8+ T-cell immunity","volume":"26","author":"Twohig","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2025.02.018_bib43","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1165\/rcmb.2012-0304OC","article-title":"Transcription of interleukin-25 and extracellular release of the protein is regulated by allergen proteases in airway epithelial cells","volume":"49","author":"Kouzaki","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2025.02.018_bib44","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2120771120","article-title":"Tumor necrosis factor\u2013like cytokine 1A plays a role in inflammatory bowel disease pathogenesis","volume":"120","author":"Meng","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.02.018_bib45","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.4049\/jimmunol.174.12.8183","article-title":"Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity","volume":"174","author":"Ying","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ni1192","article-title":"Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells","volume":"6","author":"Rimoldi","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib47","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.jaci.2022.01.029","article-title":"Mast cells instruct keratinocytes to produce thymic stromal lymphopoietin: relevance of the tryptase\/protease-activated receptor 2 axis","volume":"149","author":"Redhu","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149336","article-title":"Basal epithelial stem cells cross an alarmin checkpoint for postviral lung disease","volume":"131","author":"Wu","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.02.018_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj0474","article-title":"Tuft cell\u2013produced cysteinyl leukotrienes and IL-25 synergistically initiate lung type 2 inflammation","volume":"6","author":"Ualiyeva","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib50","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.immuni.2019.03.023","article-title":"Mechanical skin injury promotes food anaphylaxis by driving intestinal mast cell expansion","volume":"50","author":"Leyva-Castillo","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.02.018_bib51","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.immuni.2020.03.005","article-title":"Chemosensory cell-derived acetylcholine drives tracheal mucociliary clearance in response to virulence-associated formyl peptides","volume":"52","author":"Perniss","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.02.018_bib52","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41591-019-0468-5","article-title":"A cellular census of human lungs identifies novel cell states in health and in asthma","volume":"25","author":"Vieira Braga","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2008.04.021","article-title":"The TNF-family receptor DR3 is essential for diverse T cell\u2013mediated inflammatory diseases","volume":"29","author":"Meylan","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.02.018_bib54","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.4049\/jimmunol.178.7.4033","article-title":"The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells","volume":"178","author":"Prehn","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14937","article-title":"Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma","volume":"8","author":"Verstraete","year":"2017","journal-title":"Nat Commun"},{"issue":"6607","key":"10.1016\/j.jaci.2025.02.018_bib56","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/384372a0","article-title":"A death-domain\u2013containing receptor that mediates apoptosis","volume":"384","author":"Kitson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.02.018_bib57","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/jcp.20812","article-title":"Death receptor-3 mediates apoptosis in human osteoblasts under narrowly regulated conditions","volume":"209","author":"Borysenko","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jaci.2025.02.018_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060136","article-title":"The TNF-family cytokine TL1A inhibits proliferation of human activated B cells","volume":"8","author":"Cavallini","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2025.02.018_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005374","article-title":"TSLP elicits IL-33\u2013independent innate lymphoid cell responses to promote skin inflammation","volume":"5","author":"Kim","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib60","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.immuni.2016.06.017","article-title":"Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation","volume":"45","author":"Martinez-Gonzalez","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.02.018_bib61","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201354","article-title":"The molecular and epigenetic mechanisms of innate lymphoid cell (ILC) memory and its relevance for asthma","volume":"218","author":"Verma","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib62","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A role for IL-25 and IL-33\u2013driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib63","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/mi.2013.114","article-title":"The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells","volume":"7","author":"Meylan","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib64","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/mi.2013.92","article-title":"TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers","volume":"7","author":"Yu","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib65","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/eji.201445213","article-title":"Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2\u2013dependent proliferation","volume":"45","author":"Ahn","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib66","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.immuni.2018.10.014","article-title":"Microbiota-induced TNF-like ligand 1A drives group 3 innate lymphoid cell-mediated barrier protection and intestinal T cell activation during colitis","volume":"49","author":"Castellanos","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.02.018_bib67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1074-7613(02)00283-2","article-title":"TL1A is a TNF-like ligand for DR3 and TR6\/DcR3 and functions as a T cell costimulator","volume":"16","author":"Migone","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.02.018_bib68","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4049\/jimmunol.1700891","article-title":"Cleavage of TL1A differentially regulates its effects on innate and adaptive immune cells","volume":"200","author":"Ferdinand","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156540","article-title":"The ever-expanding role of cytokine receptor DR3 in T cells","volume":"176","author":"Liman","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2025.02.018_bib70","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.gene.6364097","article-title":"Death receptor 3 (DR3) gene duplication in a chromosome region 1p36.3: gene duplication is more prevalent in rheumatoid arthritis","volume":"5","author":"Osawa","year":"2004","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaci.2025.02.018_bib71","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0968-0004(01)01905-3","article-title":"The death domain superfamily: a tale of two interfaces?","volume":"26","author":"Weber","year":"2001","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jaci.2025.02.018_bib72","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/jir.1998.18.439","article-title":"Death domain receptors and their role in cell demise","volume":"18","author":"Singh","year":"1998","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jaci.2025.02.018_bib73","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00018-023-04726-7","article-title":"The cytokine receptor DR3 identifies and promotes the activation of thymic NKT17 cells","volume":"80","author":"Luo","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaci.2025.02.018_bib74","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12929-017-0347-7","article-title":"Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions","volume":"24","author":"Hsieh","year":"2017","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jaci.2025.02.018_bib75","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1073\/pnas.94.9.4615","article-title":"LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing","volume":"94","author":"Screaton","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.02.018_bib76","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/cvr\/cvz131","article-title":"Pathologic up-regulation of TNFSF15-TNFRSF25 axis sustains endothelial dysfunction in unprovoked venous thromboembolism","volume":"116","author":"Della Bella","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jaci.2025.02.018_bib77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcmgh.2023.03.008","article-title":"DR3 regulates intestinal epithelial homeostasis and regeneration after intestinal barrier injury","volume":"16","author":"Shimodaira","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2025.02.018_bib78","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.4049\/jimmunol.2000665","article-title":"TL1A promotes lung tissue fibrosis and airway remodeling","volume":"205","author":"Herro","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib79","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/1873-3468.12747","article-title":"Multifaceted death receptor 3 signaling\u2014promoting survival and triggering death","volume":"591","author":"Bittner","year":"2017","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2025.02.018_bib80","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.csbj.2020.10.008","article-title":"Functional roles in cell signaling of adaptor protein TRADD from a structural perspective","volume":"18","author":"Li","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.jaci.2025.02.018_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154744","article-title":"TNFSF\/TNFRSF cytokine gene expression in sickle cell anemia: up-regulated TNF-like cytokine 1A (TL1A) and its decoy receptor (DcR3) in peripheral blood mononuclear cells and plasma","volume":"123","author":"Safaya","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2025.02.018_bib82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/08923973.2015.1130721","article-title":"Biologics beyond TNF-alpha inhibitors and the effect of targeting the homologues TL1A-DR3 pathway in chronic inflammatory disorders","volume":"38","author":"Tougaard","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.jaci.2025.02.018_bib83","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.4049\/jimmunol.1002374","article-title":"The adaptor protein TRADD is essential for TNF-like ligand 1A\/death receptor 3 signaling","volume":"186","author":"Pobezinskaya","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib84","doi-asserted-by":"crossref","first-page":"39251","DOI":"10.1074\/jbc.M305833200","article-title":"TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells","volume":"278","author":"Wen","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2025.02.018_bib85","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2025.02.018_bib86","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20072528","article-title":"Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation","volume":"205","author":"Fang","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib87","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1073\/pnas.0510903103","article-title":"Role of TL1A and its receptor DR3 in two models of chronic murine ileitis","volume":"103","author":"Bamias","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.02.018_bib88","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1084\/jem.20071364","article-title":"TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease","volume":"205","author":"Pappu","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib89","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1189\/jlb.3A0316-129R","article-title":"The TNF family member TL1A induces IL-22 secretion in committed human Th17 cells via IL-9 induction","volume":"101","author":"Thomas","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2025.02.018_bib90","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.jaci.2021.03.015","article-title":"Roles of innate lymphoid cells (ILCs) in allergic diseases: the 10-year anniversary for ILC2s","volume":"147","author":"Bartemes","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib91","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1172\/JCI42933","article-title":"Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation","volume":"120","author":"Schreiber","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.02.018_bib92","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3389\/fimmu.2019.01624","article-title":"Activation of the DR3-TL1A axis in donor mice leads to regulatory T cell expansion and activation with reduction in graft-versus-host disease","volume":"10","author":"Mavers","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103357","article-title":"Diversity and function of regulatory T cells in health and autoimmune diseases","volume":"151","author":"Lu","year":"2025","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2025.02.018_bib94","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.molimm.2010.07.008","article-title":"Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells\u2014identification of Foxp3Delta7 in human regulatory T cells","volume":"48","author":"Kaur","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib95","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.4049\/jimmunol.1401220","article-title":"The TNF-family ligand TL1A and its receptor DR3 promote T cell\u2013mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9\u2013producing T cells","volume":"194","author":"Richard","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib96","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.mucimm.2024.03.006","article-title":"TL1A priming induces a multi-cytokine Th9 cell phenotype that promotes robust allergic inflammation in murine models of asthma","volume":"17","author":"Niese","year":"2024","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib97","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232298","article-title":"MAIT cells: conserved watchers on the wall","volume":"222","author":"Germain","year":"2025","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib98","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1016\/j.celrep.2019.08.050","article-title":"TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions","volume":"28","author":"Leng","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2025.02.018_bib99","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.4049\/jimmunol.1900465","article-title":"The TL1A-DR3 axis selectively drives effector functions in human MAIT cells","volume":"203","author":"Sattler","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jaci.2015.01.014","article-title":"Innate and adaptive T cells in asthmatic patients: relationship to severity and disease mechanisms","volume":"136","author":"Hinks","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib101","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/eji.201444528","article-title":"TL1A regulates TCRgammadelta+ intraepithelial lymphocytes and gut microbial composition","volume":"45","author":"Tougaard","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib102","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcmgh.2020.08.003","article-title":"TNFSF15 promotes antimicrobial pathways in human macrophages and these are modulated by TNFSF15 disease-risk variants","volume":"11","author":"Sun","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2025.02.018_bib103","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.4049\/jimmunol.0903782","article-title":"The TNF-like protein 1A\u2013death receptor 3 pathway promotes macrophage foam cell formation in\u00a0vitro","volume":"184","author":"McLaren","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib104","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1164\/rccm.201909-1722OC","article-title":"The role of the TL1A\/DR3 axis in the activation of group 2 innate lymphoid cells in subjects with eosinophilic asthma","volume":"202","author":"Machida","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib105","article-title":"TL1A\/DR3 axis, a key target of TNF-a, augments the epithelial-mesenchymal transformation of epithelial cells in OVA-induced asthma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib106","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.4049\/jimmunol.171.9.4868","article-title":"Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease","volume":"171","author":"Bamias","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib107","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.4049\/jimmunol.178.11.7325","article-title":"Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis","volume":"178","author":"Cassatella","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib108","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13075-020-02198-9","article-title":"Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF","volume":"22","author":"Song","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2025.02.018_bib109","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/19420862.2018.1440164","article-title":"An anti-TL1A antibody for the treatment of asthma and inflammatory bowel disease","volume":"10","author":"Clarke","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2025.02.018_bib110","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.4049\/jimmunol.174.8.4985","article-title":"Dominant role for TL1A\/DR3 pathway in IL-12 plus IL-18\u2013induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes","volume":"174","author":"Papadakis","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib111","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24984-y","article-title":"A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3","volume":"12","author":"Zwolak","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2025.02.018_bib112","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1038\/s41467-019-11304-8","article-title":"Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation","volume":"10","author":"Li","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.02.018_bib113","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1189\/jlb.3RI0315-095R","article-title":"The TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspirator","volume":"98","author":"Richard","year":"2015","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2025.02.018_bib114","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10875-010-9382-9","article-title":"TL1A selectively enhances IL-12\/IL-18\u2013induced NK cell cytotoxicity against NK-resistant tumor targets","volume":"30","author":"Heidemann","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib115","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.1404178111","article-title":"A TNFSF15 disease-risk polymorphism increases pattern-recognition receptor\u2013induced signaling through caspase-8\u2013induced IL-1","volume":"111","author":"Hedl","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.02.018_bib116","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pupt.2017.08.012","article-title":"Lung fibrosis\u2013associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts","volume":"46","author":"Bouros","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaci.2025.02.018_bib117","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1038\/s41467-023-40173-5","article-title":"Guided construction of single cell reference for human and mouse lung","volume":"14","author":"Guo","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.02.018_bib118","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/eji.201141477","article-title":"Triggering of TNFRSF25 promotes CD8+ T-cell responses and anti-tumor immunity","volume":"41","author":"Slebioda","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib119","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/mi.2012.124","article-title":"TL1A\/TNFSF15 directly induces proinflammatory cytokines, including TNFalpha, from CD3+CD161+ T cells to exacerbate gut inflammation","volume":"6","author":"Jin","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cyto.2013.06.315","article-title":"Regulation of ADAMTS-1, -4 and -5 expression in human macrophages: differential regulation by key cytokines implicated in atherosclerosis and novel synergism between TL1A and IL-17","volume":"64","author":"Ashlin","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2025.02.018_bib121","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20140678","article-title":"CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22","volume":"211","author":"Longman","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085793","article-title":"TL1A induces TCR independent IL-6 and TNF-alpha production and growth of PLZF+ leukocytes","volume":"9","author":"Reichwald","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2025.02.018_bib123","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cyto.2014.04.007","article-title":"TL1A increased the differentiation of peripheral Th17 in rheumatoid arthritis","volume":"69","author":"Zhou","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2025.02.018_bib124","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/mi.2014.87","article-title":"A major population of mucosal memory CD4+ T cells, coexpressing IL-18Ralpha and DR3, display innate lymphocyte functionality","volume":"8","author":"Holmkvist","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib125","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-024-01180-8","article-title":"TL1A and IL-18 synergy promotes GM-CSF\u2013dependent thymic granulopoiesis in mice","volume":"21","author":"Ruiz Perez","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib126","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejim.2024.05.011","article-title":"Towards precision medicine in COPD: targeting type 2 cytokines and alarmins","volume":"125","author":"Varricchi","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib127","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3389\/fimmu.2018.02601","article-title":"The pleiotropic immunomodulatory functions of IL-33 and its implications in tumor immunity","volume":"9","author":"Afferni","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib128","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41577-018-0006-6","article-title":"Targeting cytokines to treat asthma and chronic obstructive pulmonary disease","volume":"18","author":"Barnes","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib129","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1164\/rccm.202009-3631CI","article-title":"Severe adult asthmas: integrating clinical features, biology, and therapeutics to improve outcomes","volume":"203","author":"Wenzel","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S2213-2600(21)00023-0","article-title":"Neutrophilic asthma: misconception or misnomer?","volume":"9","author":"Nair","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib131","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.chest.2021.04.013","article-title":"Eosinophilic and noneosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort","volume":"160","author":"Heaney","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2025.02.018_bib132","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.anai.2019.08.462","article-title":"Evaluating direct costs and productivity losses of patients with asthma receiving GINA 4\/5 therapy in the United States","volume":"123","author":"Settipane","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib133","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2213-2600(20)30397-0","article-title":"Composite type-2 biomarker strategy versus a symptom-risk\u2013based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial","volume":"9","author":"Heaney","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib134","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/thoraxjnl-2020-215168","article-title":"Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era","volume":"76","author":"Jackson","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2025.02.018_bib135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaci.2020.12.628","article-title":"IL-25 (IL-17E) in epithelial immunology and pathophysiology","volume":"148","author":"Borowczyk","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107839","article-title":"Therapeutic targets in lung tissue remodelling and fibrosis","volume":"225","author":"Liu","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaci.2025.02.018_bib137","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.200207-710OC","article-title":"Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone","volume":"167","author":"Chetta","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib138","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1111\/all.15473","article-title":"Biologics and airway remodeling in severe asthma","volume":"77","author":"Varricchi","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.02.018_bib139","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00117-2020","article-title":"Suboptimal treatment response to anti\u2013IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena","volume":"56","author":"Mukherjee","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.02.018_bib140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4168\/aair.2022.14.2.233","article-title":"The TL1A-DR3 axis in asthma: membrane-bound and secreted TL1A co-determined the development of airway remodeling","volume":"14","author":"Zhang","year":"2022","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2025.02.018_bib141","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/all.14952","article-title":"Genome-wide association study identifies TNFSF15 associated with childhood asthma","volume":"77","author":"Kim","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.02.018_bib142","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01619-2023","article-title":"Airway remodelling in asthma and the epithelium: on the edge of a new era","volume":"63","author":"Varricchi","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.02.018_bib143","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fmed.2020.00191","article-title":"Airway remodeling in asthma","volume":"7","author":"Hough","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2025.02.018_bib144","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3389\/fphar.2019.01148","article-title":"Crosstalk between signaling pathways involved in the regulation of airway smooth muscle cell hyperplasia","volume":"10","author":"Yap","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2025.02.018_bib145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/pai.13040","article-title":"Interleukin-33 in the developing lung\u2014roles in asthma and infection","volume":"30","author":"Johansson","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib146","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/13543784.2019.1672657","article-title":"Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma","volume":"28","author":"Marone","year":"2019","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaci.2025.02.018_bib147","doi-asserted-by":"crossref","DOI":"10.1111\/all.16382","article-title":"Biologics and airway remodeling in asthma: early, late, and potential preventive effects","author":"Varricchi","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.02.018_bib148","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-042220-015902","article-title":"The pathology of asthma: what is obstructing our view?","volume":"18","author":"Aegerter","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaci.2025.02.018_bib149","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.02.018_bib150","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3389\/fphar.2019.01387","article-title":"The intriguing role of interleukin 13 in the pathophysiology of asthma","volume":"10","author":"Marone","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2025.02.018_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.692127","article-title":"Targeting TL1A\/DR3 signaling offers a therapeutic advantage to neutralizing IL13\/IL4Ralpha in muco-secretory fibrotic disorders","volume":"12","author":"Steele","year":"2021","journal-title":"Front Immunol"},{"issue":"7796","key":"10.1016\/j.jaci.2025.02.018_bib152","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41586-020-2025-2","article-title":"Pathway paradigms revealed from the genetics of inflammatory bowel disease","volume":"578","author":"Graham","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.02.018_bib153","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2025.02.018_bib154","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.gastro.2020.04.074","article-title":"Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn\u2019s disease","volume":"159","author":"Mitsialis","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2025.02.018_bib155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/gutjnl-2013-305193","article-title":"Genome-wide association study of Crohn\u2019s disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations","volume":"63","author":"Yang","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2025.02.018_bib156","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/ped.12686","article-title":"Association of TNFSF15 polymorphisms in Korean children with Crohn\u2019s disease","volume":"57","author":"Lee","year":"2015","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jaci.2025.02.018_bib157","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"issue":"5289","key":"10.1016\/j.jaci.2025.02.018_bib158","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.274.5289.990","article-title":"Signal transduction by DR3, a death domain\u2013containing receptor related to TNFR-1 and CD95","volume":"274","author":"Chinnaiyan","year":"1996","journal-title":"Science"},{"issue":"10014","key":"10.1016\/j.jaci.2025.02.018_bib159","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","article-title":"Inherited determinants of Crohn\u2019s disease and ulcerative colitis phenotypes: a genetic association study","volume":"387","author":"Cleynen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.02.018_bib160","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/hmg\/ddac269","article-title":"Trans-ancestry, Bayesian meta-analysis discovers 20 novel risk loci for inflammatory bowel disease in an African American, East Asian and European cohort","volume":"32","author":"Cordero","year":"2023","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaci.2025.02.018_bib161","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ecco-jcc\/jjaa165","article-title":"Gut microbial transcytosis induced by tumor necrosis factor\u2013like 1A\u2013dependent activation of a myosin light chain kinase splice variant contributes to IBD","volume":"15","author":"Pai","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jaci.2025.02.018_bib162","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajpath.2011.10.026","article-title":"Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis","volume":"180","author":"Barrett","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2025.02.018_bib163","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.trsl.2016.08.007","article-title":"Crohn\u2019s disease\u2013associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells","volume":"180","author":"Bamias","year":"2017","journal-title":"Transl Res"},{"key":"10.1016\/j.jaci.2025.02.018_bib164","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41385-018-0055-y","article-title":"Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome","volume":"11","author":"Jacob","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.prp.2017.11.017","article-title":"TL1A blocking ameliorates intestinal fibrosis in the T cell transfer model of chronic colitis in mice","volume":"214","author":"Li","year":"2018","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.jaci.2025.02.018_bib166","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/bcp.14187","article-title":"First-in-human, randomized dose-escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF-06480605 in healthy subjects","volume":"86","author":"Banfield","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2025.02.018_bib167","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa2314076","article-title":"Phase 2 trial of anti-TL1A monoclonal antibody tulisokibart for ulcerative colitis","volume":"391","author":"Sands","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib168","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.4049\/jimmunol.0802645","article-title":"Role of TL1A in the pathogenesis of rheumatoid arthritis","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib169","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1084\/jem.20072378","article-title":"The death receptor 3\u2013TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis","volume":"205","author":"Bull","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.02.018_bib170","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jaad.2018.02.040","article-title":"Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis","volume":"79","author":"Lockshin","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2025.02.018_bib171","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00403-019-02030-8","article-title":"Effects of tumor necrosis factor-like ligand 1A (TL1A) on imiquimod-induced psoriasiform skin inflammation in mice","volume":"312","author":"Li","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2025.02.018_bib172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007458","article-title":"Reduced monocyte and macrophage TNFSF15\/TL1A expression is associated with susceptibility to inflammatory bowel disease","volume":"14","author":"Richard","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jaci.2025.02.018_bib173","article-title":"Role of TL1A in inflammatory autoimmune diseases: a comprehensive review","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.018_bib174","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaci.2025.02.018_bib175","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ibd\/izab193","article-title":"Antitumor necrosis factor\u2013like ligand 1A therapy targets tissue inflammation and fibrosis pathways and reduces gut pathobionts in ulcerative colitis","volume":"28","author":"Hassan-Zahraee","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2025.02.018_bib176","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/1744666X.2016.1208564","article-title":"The role of interleukin 5 in asthma","volume":"12","author":"Varricchi","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2025.02.018_bib177","article-title":"Development and characterization of SPY002, a novel extended half-life monoclonal antibody drug candidate targeting TL1A for the treatment of IBD","volume":"18","author":"Zhu","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jaci.2025.02.018_bib178","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cgh.2021.06.011","article-title":"Anti-TL1A antibody PF-06480605 safety and efficacy for ulcerative colitis: a phase 2a single-arm study","volume":"19","author":"Danese","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"suppl","key":"10.1016\/j.jaci.2025.02.018_bib179","article-title":"P998 Phase 2 basket design study evaluating the efficacy and safety of an anti-TL1A antibody (TEV-48574) in moderate to severe ulcerative colitis or Crohn\u2019s disease (RELIEVE UCCD)","volume":"18","author":"Reinisch","year":"2024","journal-title":"J Crohn Colitis"},{"issue":"suppl","key":"10.1016\/j.jaci.2025.02.018_bib180","doi-asserted-by":"crossref","first-page":"i162","DOI":"10.1093\/ecco-jcc\/jjac190.0127","article-title":"DOP87 The anti-TL1A antibody PRA023 demonstrated proof-of-concept in Crohn\u2019s disease: phase 2a APOLLO-CD study results","volume":"17","author":"Feagan","year":"2023","journal-title":"J Crohns Colitis"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925002143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925002143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:28:46Z","timestamp":1777264126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925002143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":180,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0091674925002143"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.02.018","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TL1A, a novel alarmin in airway, intestinal, and autoimmune disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}